These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4129688

  • 21. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
    Biondo FG, Caldarelli L, Bergaminelli C, Perillo G.
    Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
    [No Abstract] [Full Text] [Related]

  • 22. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L, Tsougranis A.
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [Abstract] [Full Text] [Related]

  • 23. [Circulating immunocomplexes in lung neoplasms].
    Pesek M, Sefrna F, Simecek C, Racek J.
    Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
    [No Abstract] [Full Text] [Related]

  • 24. Immune status in lung cancer: effects of BCG immunotherapy.
    Gross NJ, Eddie-Quartey AC.
    Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
    [Abstract] [Full Text] [Related]

  • 25. Mixed lymphocyte reactivity of patients with solid tumors.
    Harris J, Stewart TH.
    Oncology; 1974 Apr; 30(1):33-42. PubMed ID: 4280032
    [No Abstract] [Full Text] [Related]

  • 26. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. 3. Chronic lymphatic leukaemia.
    Libánský J, Lukásová M, Pinosová I.
    Neoplasma; 1973 Apr; 20(1):69-77. PubMed ID: 4702206
    [No Abstract] [Full Text] [Related]

  • 27. Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders.
    Dellon AL, Ptovin C, Chretien PB.
    Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):500-11. PubMed ID: 164781
    [No Abstract] [Full Text] [Related]

  • 28. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY, Samuels ML, Smith T, Sinkovics JG.
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [Abstract] [Full Text] [Related]

  • 29. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R, Stark M, Idel H.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [Abstract] [Full Text] [Related]

  • 30. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
    Yanagawa E, Yasumoto K, Manabe H, Nagano N, Hirota N, Ohta M, Hattori T, Nomoto K, Azuma I, Yamamura Y.
    Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
    [Abstract] [Full Text] [Related]

  • 31. [Immunomorphology of lymph nodes and prognosis in lung cancer].
    Di Giorgio A, Sammartino P, Canavese A, Arnone P, Sibio S, Accarpio F, Al Mansour M.
    Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
    [Abstract] [Full Text] [Related]

  • 32. Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment.
    Dellon AL, Potvin C, Chretien PB.
    Cancer; 1975 Mar; 35(3):687-94. PubMed ID: 163138
    [Abstract] [Full Text] [Related]

  • 33. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
    Takita H, Brugarolas A.
    J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
    [No Abstract] [Full Text] [Related]

  • 34. Neuraminidase-mediated augmentation of in vitro immune response of patients with solid tumors.
    Watkins E, Gray BN, Anderson LL, Baralt OL, Nebril LR, Waters MF, Connery CK.
    Int J Cancer; 1974 Dec 15; 14(6):799-807. PubMed ID: 4377008
    [Abstract] [Full Text] [Related]

  • 35. Immunochemotherapy with Corynebacterium parvum in disseminated cancer.
    Israel L.
    Ann N Y Acad Sci; 1976 Dec 15; 277(00):241-51. PubMed ID: 187100
    [No Abstract] [Full Text] [Related]

  • 36. [Prognostic value of the assessment of nonspecific immunologic reactivity in lung cancer].
    Porwit-Ksiazek A.
    Nowotwory; 1982 Dec 15; 32(1-2):71-80. PubMed ID: 6294626
    [No Abstract] [Full Text] [Related]

  • 37. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE, DeVald B.
    Cancer Res; 1975 Dec 15; 35(12):3577-84. PubMed ID: 1192421
    [Abstract] [Full Text] [Related]

  • 38. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA.
    Schweiz Med Wochenschr; 1971 Apr 03; 101(13):470-4. PubMed ID: 5283773
    [No Abstract] [Full Text] [Related]

  • 39. The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.
    Anthony HM, Templeman GH, Madsen KE, Mason MK.
    Cancer; 1974 Dec 03; 34(6):1901-6. PubMed ID: 4373163
    [No Abstract] [Full Text] [Related]

  • 40. Immunomodulation by bronchial lavage cells in normal individuals and patients with bronchogenic carcinoma.
    Weissman DN, deShazo RD, Banks DE, Baser Y.
    Am J Med Sci; 1986 Oct 03; 292(4):187-92. PubMed ID: 3019138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.